Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 14, 2019; 25(14): 1764-1774
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Figure 1 Flow-chart of the study.
CD: Crohn’s Disease; CDEIS: Crohn's Disease Endoscopic Index of Severity; TNF: Tumor necrosis factor.
- Citation: Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774
- URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1764